You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HRTX Exercise Disclosure
Duarte Ira · SEC Form 4 · Filed Aug 3, 2026
Exercise
Reported value range
Not reported
Duarte Ira EVP, Chief Financial Officer
HRTX
Heron Therapeutics
HRTX
Transaction date
Jul 30, 2026
Public filing date
Aug 3, 2026
Filing lag
Filed 4 days later
HRTX daily price context
Close on/before transaction
$0.5
Jul 30, 2026
First close after public filing
$0.51
Aug 3, 2026
30-day return after filing
-38.82%
Through Sep 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 13,535 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-329720
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$3.59K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Heron Therapeutics, Inc. /De/ HRTX | Exercise | Jul 31, 2026 | Not reported |
| Heron Therapeutics, Inc. /De/ HRTX | Disposition | Jul 31, 2026 | $1.66K |
| Heron Therapeutics, Inc. /De/ HRTX | Exercise | Jul 31, 2026 | $0 |
| Heron Therapeutics, Inc. /De/ HRTX Current | Exercise | Jul 30, 2026 | Not reported |
| Heron Therapeutics, Inc. /De/ HRTX | Disposition | Jul 30, 2026 | $1.93K |
| Heron Therapeutics, Inc. /De/ HRTX | Exercise | Jul 30, 2026 | $0 |